24 Recruiting Alopecia Areata Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Alopecia Areata Studies
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
📍 Total Skin and Beauty Dermatology Center — Birmingham, Alabama
View Study & Checklist ➔Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
📍 University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
📍 CorEvitas, LLC — Waltham, Massachusetts
View Study & Checklist ➔A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
📍 Dren Investigational Site — Northridge, California
View Study & Checklist ➔A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
📍 Nektar Investigative Site — Northridge, California
View Study & Checklist ➔Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
📍 Total Skin And Beauty Dermatology Center — Birmingham, Alabama
View Study & Checklist ➔Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
📍 Hospital Universitario "Dr. José Eleuterio González" — Monterrey, Nuevo León
View Study & Checklist ➔Dupilumab in the Treatment of Pediatric Alopecia Areata
📍 University of California, Irvine — Irvine, California
View Study & Checklist ➔Alopecia Areata Registry
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
📍 The Kirklin Clinic of UAB Hospital (Radiology) — Birmingham, Alabama
View Study & Checklist ➔Intralesional Cyclosporine for Alopecia Areata
📍 University of California, Davis - Dermatology Department — Sacramento, California
View Study & Checklist ➔A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
📍 Total Skin and Beauty Dermatology Center /ID# 259539 — Birmingham, Alabama
View Study & Checklist ➔Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)
📍 Scottsdale, Arizona — Scottsdale, Arizona
View Study & Checklist ➔A Study of LAD603 in Adults With Alopecia Areata
📍 Investigator Site 1 — Omaha, Nebraska
View Study & Checklist ➔Regeneron AA Multicenter (Dupilumab)
📍 University of California, Irvine — Irvine, California
View Study & Checklist ➔A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
📍 California Dermatology & Clinical Research Institute — Encinitas, California
View Study & Checklist ➔CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
📍 CorEvitas, LLC — Waltham, Massachusetts
View Study & Checklist ➔A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
📍 Center For Dermatology Clinical Research, Inc. — Fremont, California
View Study & Checklist ➔